John M. Leonard
2012 - AbbVie
In 2012, John M. Leonard earned a total compensation of $5.5M as Senior Vice President, Pharmaceuticals, Research and Development at AbbVie, a 57% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,719,253 |
|---|---|
| Non-Equity Incentive Plan | $515,600 |
| Option Awards | $224,400 |
| Salary | $640,163 |
| Stock Awards | $2,229,557 |
| Other | $149,142 |
| Total | $5,478,115 |
Leonard received $2.2M in stock awards, accounting for 41% of the total pay in 2012.
Leonard also received $1.7M of change in pension value and nonqualified deferred compensation earnings, $515.6K in non-equity incentive plan, $224.4K in option awards, $640.2K in salary and $149.1K in other compensation.
Rankings
In 2012, John M. Leonard's compensation ranked 1,075th out of 11,487 executives tracked by ExecPay. In other words, Leonard earned more than 90.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,075 out of 11,487 | 91st |
Division Manufacturing | 388 out of 4,253 | 91st |
Major group Chemicals And Allied Products | 90 out of 1,198 | 93rd |
Industry group Drugs | 51 out of 920 | 95th |
Industry Pharmaceutical Preparations | 45 out of 700 | 94th |
Source: SEC filing on March 15, 2013.
Leonard's colleagues
We found four more compensation records of executives who worked with John M. Leonard at AbbVie in 2012.